乾癬性関節炎治療市場レポート：2030年までの動向、予測、競合分析

乾癬性関節炎の治療動向と予測

世界の乾癬性関節炎治療市場は、2024年から2030年までのCAGRが9.6%で、2030年までに推定157億7,000万米ドルに達すると予想されています。この市場の主な促進要因は、高齢者人口の増加と乾癬性関節炎の有病率の増加、商品需要の増加です。乾癬性関節炎の治療に関する研究開発の取り組みが急増しており、乾癬性関節炎の治療に関する知識の増加に加えて、乾癬性関節炎に対する新薬、生物学的製剤およびバイオシミラー医薬品の強力なパイプラインを提供するための研究開発活動が急増しています。世界の乾癬性関節炎治療市場の将来は、病院薬局、小売薬局、オンライン薬局市場にチャンスがあり、有望に見えます。

乾癬性関節炎治療市場に関する洞察

Lucintelは、生物学的疾患修飾性抗リウマチ薬は、病気の管理における有効性の結果として生物学的治療の使用が増加しているため、予測期間中に最高の成長を遂げると予測しています。

アジア太平洋地域は、乾癬性関節炎の発生率とジェネリック医薬品の量の増加により、予測期間中に最も高い成長が見込まれると予想されます。

よくある質問

Q.1乾癬性関節炎治療の市場規模はどれくらいですか：

A1.世界の乾癬性関節炎治療市場は、2030年までに推定157億7,000万米ドルに達すると予想されています。

Q.2乾癬性関節炎治療市場の成長予測はどの程度ですか：

A2.世界の乾癬性関節炎治療市場は、2024年から2030年にかけて9.6%のCAGRで成長すると予想されています。

Q.3乾癬性関節炎治療市場の成長に影響を与える主な要因は何ですか：

A3.この市場の主な促進要因は、高齢者人口の増加と乾癬性関節炎の有病率の増加、乾癬性関節炎を治療する製品の需要の増加です。乾癬性関節炎の治療に関する研究開発の取り組みが急増しており、乾癬性関節炎の治療に関する知識の増加に加えて、乾癬性関節炎に対する新薬、生物学的製剤およびバイオシミラー医薬品の強力なパイプラインを提供するための研究開発活動が急増しています。

Q4.市場の主要セグメントは：

A4.乾癬性関節炎治療市場の将来は、病院薬局、小売薬局、オンライン薬局市場にチャンスがあり、有望に見えます。

Q5.市場の主要企業は：

A5.主要な乾癬性関節炎治療会社は以下のとおりです。

• F. Hoffmann-La Roche
• Novartis
• Amgen
• Pfizer
• Johnson &Johnson Services
• Eli Lilly and Company
• AstraZeneca
• Sanofi
• Bristol-Myers Squibb Company
• GlaxoSmithKline

Q6.今後、最大となる市場セグメントは：

A6.Lucintelは、生物学的疾患修飾性抗リウマチ薬は、病気の管理における有効性の結果として生物学的治療の使用が増加しているため、予測期間中に最高の成長を遂げると予測しています。

Q7.市場において、今後5年間に最大になると予想される地域は：

A7.アジア太平洋地域は、乾癬性関節炎の発生率とジェネリック医薬品の量の増加により、予測期間中に最も高い成長が見込まれると予想されます。

Q8.レポートのカスタマイズは可能か：

A8.はい、Lucintelは追加費用なしで10%のカスタマイズを提供します。

目次

第1章 エグゼクティブサマリー

第2章 世界の乾癬性関節炎治療市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

• マクロ経済動向（2018～2023年）と予測（2024～2030年）
• 世界の乾癬性関節炎治療市場の動向（2018～2023年）と予測（2024～2030年）
• 医薬品クラス別の世界の乾癬性関節炎治療市場
  • 非ステロイド性抗炎症薬
  • 非生物学的疾患修飾性抗リウマチ薬
  • 生物学的疾患修飾性抗リウマチ薬
  • その他
• 投与経路別の世界の乾癬性関節炎治療市場
  • 経口
  • 非経口
  • 外用
• 流通チャネル別の世界の乾癬性関節炎治療市場
  • 病院薬局
  • 小売薬局
  • オンライン薬局

第4章 2018年から2030年までの地域別の市場動向と予測分析

• 地域別の世界の乾癬性関節炎治療市場
• 北米の乾癬性関節炎治療市場
• 欧州の乾癬性関節炎治療市場
• アジア太平洋の乾癬性関節炎治療市場
• その他地域の乾癬性関節炎治療市場

第5章 競合の分析

• 製品ポートフォリオ分析
• 運用上の統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

• 成長機会分析
  • 医薬品クラス別の世界の乾癬性関節炎治療市場の成長機会
  • 投与経路別の世界の乾癬性関節炎治療市場の成長機会
  • 流通チャネル別の世界の乾癬性関節炎治療市場の成長機会
  • 地域別の世界の乾癬性関節炎治療市場の成長機会
• 世界の乾癬性関節炎治療市場の新たな動向
• 戦略的分析
  • 新製品の開発
  • 世界の乾癬性関節炎治療市場の能力拡大
  • 世界の乾癬性関節炎治療市場における合併、買収、合弁事業
  • 認証とライセンシング

第7章 有力企業の企業プロファイル

• F. Hoffmann-La Roche
• Novartis
• Amgen
• Pfizer
• Johnson & Johnson Services
• Eli Lilly and Company
• AstraZeneca
• Sanofi
• Bristol-Myers Squibb Company
• GlaxoSmithKline

Psoriatic Arthritis Treatment Trends and Forecast

The future of the global psoriatic arthritis treatment market looks promising with opportunities in the hospital pharmacies, retail pharmacies, and online pharmacies markets. The global psoriatic arthritis treatment market is expected to reach an estimated $15.77 billion by 2030 with a CAGR of 9.6% from 2024 to 2030. The major drivers for this market are rise in the senior population and psoriatic arthritis prevalence, increase in the demand for goods that treat psoriatic arthritis and a spike in research and development efforts to provide new medications for the condition, and robust pipeline of biologic and biosimilar drugs, as well as increased knowledge of psoriatic arthritis therapy.

A more than 150-page report is developed to help in your business decisions.

Psoriatic Arthritis Treatment by Segment

The study includes a forecast for the global psoriatic arthritis treatment by drugs class, route of administration , distribution channel, and region.

Psoriatic Arthritis Treatment Market by Drugs Class [Shipment Analysis by Value from 2018 to 2030]:

• Non-steroidal Anti-inflammatory Drugs
• Non-biologic Disease Modifying Anti-Rheumatic Drugs
• Biologic Disease Modifying Anti-Rheumatic Drugs
• Others

Psoriatic Arthritis Treatment Market by Route of Administration [Shipment Analysis by Value from 2018 to 2030]:

• Oral
• Parenteral
• Topical

Psoriatic Arthritis Treatment Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Psoriatic Arthritis Treatment Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Psoriatic Arthritis Treatment Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies psoriatic arthritis treatment companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the psoriatic arthritis treatment companies profiled in this report include-

• F. Hoffmann-La Roche
• Novartis
• Amgen
• Pfizer
• Johnson & Johnson Services
• Eli Lilly And Company
• Astrazeneca
• Sanofi
• Bristol-Myers Squibb Company
• Glaxosmithkline

Psoriatic Arthritis Treatment Market Insights

Lucintel forecasts that biologic disease modifying anti-rheumatic drugs is expected to witness highest growth over the forecast period due to increasing use of biological treatments as a result of their effectiveness in managing the illness.

APAC is expected to witness highest growth over the forecast period due to rising rates of psoriatic arthritis instances and the quantity of generic medications.

Features of the Global Psoriatic Arthritis Treatment Market

Market Size Estimates: Psoriatic arthritis treatment market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Psoriatic arthritis treatment market size by drugs class, route of administration , distribution channel, and region in terms of value ($B).

Regional Analysis: Psoriatic arthritis treatment market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different drugs class, route of administration , distribution channel, and regions for the psoriatic arthritis treatment market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the psoriatic arthritis treatment market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the psoriatic arthritis treatment market size?

Answer: The global psoriatic arthritis treatment market is expected to reach an estimated $15.77 billion by 2030.

Q.2 What is the growth forecast for psoriatic arthritis treatment market?

Answer: The global psoriatic arthritis treatment market is expected to grow with a CAGR of 9.6% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the psoriatic arthritis treatment market?

Answer: The major drivers for this market are rise in the senior population and psoriatic arthritis prevalence, increase in the demand for goods that treat psoriatic arthritis and a spike in research and development efforts to provide new medications for the condition, and robust pipeline of biologic and biosimilar drugs, as well as increased knowledge of psoriatic arthritis therapy.

Q4. What are the major segments for psoriatic arthritis treatment market?

Answer: The future of the psoriatic arthritis treatment market looks promising with opportunities in the hospital pharmacies, retail pharmacies, and online pharmacies markets.

Q5. Who are the key psoriatic arthritis treatment market companies?

Answer: Some of the key psoriatic arthritis treatment companies are as follows.

• F. Hoffmann-La Roche
• Novartis
• Amgen
• Pfizer
• Johnson & Johnson Services
• Eli Lilly and Company
• AstraZeneca
• Sanofi
• Bristol-Myers Squibb Company
• GlaxoSmithKline

Q6. Which psoriatic arthritis treatment market segment will be the largest in future?

Answer: Lucintel forecasts that biologic disease modifying anti-rheumatic drugs is expected to witness highest growth over the forecast period due to increasing use of biological treatments as a result of their effectiveness in managing the illness.

Q7. In psoriatic arthritis treatment market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness highest growth over the forecast period due to rising rates of psoriatic arthritis instances and the quantity of generic medications.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the psoriatic arthritis treatment market by drugs class (non-steroidal anti-inflammatory drugs, non-biologic disease modifying anti-rheumatic drugs, biologic disease modifying anti-rheumatic drugs, and others), route of administration (oral, parenteral, and topical), distribution channel (hospital pharmacies, retail pharmacies, and online pharmacies), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Psoriatic Arthritis Treatment Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Psoriatic Arthritis Treatment Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Psoriatic Arthritis Treatment Market by Drugs Class
  • 3.3.1: Non-steroidal Anti-inflammatory Drugs
  • 3.3.2: Non-biologic Disease Modifying Anti-Rheumatic Drugs
  • 3.3.3: Biologic Disease Modifying Anti-Rheumatic Drugs
  • 3.3.4: Others
• 3.4: Global Psoriatic Arthritis Treatment Market by Route of Administration
  • 3.4.1: Oral
  • 3.4.2: Parenteral
  • 3.4.3: Topical
• 3.5: Global Psoriatic Arthritis Treatment Market by Distribution Channel
  • 3.5.1: Hospital Pharmacies
  • 3.5.2: Retail Pharmacies
  • 3.5.3: Online Pharmacies

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Psoriatic Arthritis Treatment Market by Region
• 4.2: North American Psoriatic Arthritis Treatment Market
  • 4.2.2: North American Psoriatic Arthritis Treatment Market by Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies
• 4.3: European Psoriatic Arthritis Treatment Market
  • 4.3.1: European Psoriatic Arthritis Treatment Market by Drugs Class: Non-steroidal Anti-inflammatory Drugs, Non-biologic Disease Modifying Anti-Rheumatic Drugs, Biologic Disease Modifying Anti-Rheumatic Drugs, and Others
  • 4.3.2: European Psoriatic Arthritis Treatment Market by Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies
• 4.4: APAC Psoriatic Arthritis Treatment Market
  • 4.4.1: APAC Psoriatic Arthritis Treatment Market by Drugs Class: Non-steroidal Anti-inflammatory Drugs, Non-biologic Disease Modifying Anti-Rheumatic Drugs, Biologic Disease Modifying Anti-Rheumatic Drugs, and Others
  • 4.4.2: APAC Psoriatic Arthritis Treatment Market by Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies
• 4.5: ROW Psoriatic Arthritis Treatment Market
  • 4.5.1: ROW Psoriatic Arthritis Treatment Market by Drugs Class: Non-steroidal Anti-inflammatory Drugs, Non-biologic Disease Modifying Anti-Rheumatic Drugs, Biologic Disease Modifying Anti-Rheumatic Drugs, and Others
  • 4.5.2: ROW Psoriatic Arthritis Treatment Market by Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Psoriatic Arthritis Treatment Market by Drugs Class
  • 6.1.2: Growth Opportunities for the Global Psoriatic Arthritis Treatment Market by Route of Administration
  • 6.1.3: Growth Opportunities for the Global Psoriatic Arthritis Treatment Market by Distribution Channel
  • 6.1.4: Growth Opportunities for the Global Psoriatic Arthritis Treatment Market by Region
• 6.2: Emerging Trends in the Global Psoriatic Arthritis Treatment Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Psoriatic Arthritis Treatment Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Psoriatic Arthritis Treatment Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: F. Hoffmann-La Roche
• 7.2: Novartis
• 7.3: Amgen
• 7.4: Pfizer
• 7.5: Johnson & Johnson Services
• 7.6: Eli Lilly and Company
• 7.7: AstraZeneca
• 7.8: Sanofi
• 7.9: Bristol-Myers Squibb Company
• 7.10: GlaxoSmithKline